These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12791658)

  • 1. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress.
    Libura M; Asnafi V; Tu A; Delabesse E; Tigaud I; Cymbalista F; Bennaceur-Griscelli A; Villarese P; Solbu G; Hagemeijer A; Beldjord K; Hermine O; Macintyre E
    Blood; 2003 Sep; 102(6):2198-204. PubMed ID: 12791658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.
    Christiansen DH; Pedersen-Bjergaard J
    Leukemia; 2001 Dec; 15(12):1848-51. PubMed ID: 11753604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLT3 mutations are associated with other molecular lesions in AML.
    Carnicer MJ; Nomdedéu JF; Lasa A; Estivill C; Brunet S; Aventín A; Sierra J
    Leuk Res; 2004 Jan; 28(1):19-23. PubMed ID: 14630076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
    Chillón MC; Fernández C; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; González M; Miguel JF
    Hematol J; 2004; 5(3):239-46. PubMed ID: 15167911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
    Olesen LH; Nyvold CG; Aggerholm A; Nørgaard JM; Guldberg P; Hokland P
    Eur J Haematol; 2005 Sep; 75(3):185-92. PubMed ID: 16104873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.
    Taketani T; Taki T; Sugita K; Furuichi Y; Ishii E; Hanada R; Tsuchida M; Sugita K; Ida K; Hayashi Y
    Blood; 2004 Feb; 103(3):1085-8. PubMed ID: 14504097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia.
    Jamal R; Taketani T; Taki T; Bessho F; Hongo T; Hamaguchi H; Horiike S; Taniwaki M; Hanada R; Nakamura H; Hayashi Y
    Genes Chromosomes Cancer; 2001 Jun; 31(2):187-90. PubMed ID: 11319806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
    Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
    Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
    Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
    Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
    Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.
    Armstrong SA; Kung AL; Mabon ME; Silverman LB; Stam RW; Den Boer ML; Pieters R; Kersey JH; Sallan SE; Fletcher JA; Golub TR; Griffin JD; Korsmeyer SJ
    Cancer Cell; 2003 Feb; 3(2):173-83. PubMed ID: 12620411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 11q23/MLL rearrangements.
    Johansson B; Fioretos T; Kullendorff CM; Wiebe T; Békássy AN; Garwicz S; Forestier E; Roos G; Akerman M; Mitelman F; Billström R
    Genes Chromosomes Cancer; 2000 Feb; 27(2):136-42. PubMed ID: 10612801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.
    Shiah HS; Kuo YY; Tang JL; Huang SY; Yao M; Tsay W; Chen YC; Wang CH; Shen MC; Lin DT; Lin KH; Tien HF
    Leukemia; 2002 Feb; 16(2):196-202. PubMed ID: 11840285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological & molecular profile of acute myelogenous leukaemia in India.
    Sazawal S; Kumar B; Hasan SK; Dutta P; Kumar R; Chaubey R; Mir R; Saxena R
    Indian J Med Res; 2009 Mar; 129(3):256-61. PubMed ID: 19491417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group.
    Shimada A; Taki T; Tabuchi K; Taketani T; Hanada R; Tawa A; Tsuchida M; Horibe K; Tsukimoto I; Hayashi Y
    Pediatr Blood Cancer; 2008 Feb; 50(2):264-9. PubMed ID: 17763464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal origin of childhood AML occurs less frequently than in childhood ALL.
    Burjanivova T; Madzo J; Muzikova K; Meyer C; Schneider B; Votava F; Marschalek R; Stary J; Trka J; Zuna J
    BMC Cancer; 2006 Apr; 6():100. PubMed ID: 16630339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.